Overview

An Open Protocol for the Compassionate Use of Thalidomide

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the use of thalidomide for the treatment of cancer. Patients with many types of cancers will be enrolled because the researchers will also study how the different cancers respond and what kind of side effects patients will experience.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Arkansas
Treatments:
Thalidomide